Back to search
FDAFDA · Food and drugs·Recall number Z-2081-2019

GammaPod Stereotactic Radiotherapy System Model A, REF XMSGP030A00-0.02 Product Usage: GammaPod is a teletherapy device intended for use in the noninvasive stereotactic delivery of a radiation dose to a partial volume of the breast in conjunction with breast conserving treatment.

Published July 31, 2019 · Recall initiated: July 3, 2019

Summary

FDA records medical device Class II recall Z-2081-2019, published July 31, 2019 and initiated July 3, 2019. Recalling firm: Xcision Medical Systems, LLC; Status: Terminated; Reported quantity: 2; Lot: Serial Numbers GP0002, GP0004; UDI: (01) 00850002615005. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

One bolt on the V motor was not fully tightened which caused a drift of .13 degrees in alignment resulting in reduced dose output.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Xcision Medical Systems, LLC
Distributor
The products were distributed to the following US states: MD and TX.
Lot
Serial Numbers GP0002, GP0004; UDI: (01) 00850002615005
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was GammaPod Stereotactic Radiotherapy System Model A, REF XMSGP030A00-0.02 Product Usage: GammaPod is a teletherapy device intended for use in the noninvasive stereotactic delivery of a radiation dose to a partial volume of the breast in conjunction with breast conserving treatment. recalled?

Yes. FDA published recall Z-2081-2019 on July 31, 2019. Reported hazard: One bolt on the V motor was not fully tightened which caused a drift of .13 degrees in alignment resulting in reduced dose output.

What should I do if I have this product?

Voluntary: Firm initiated · Letter